Coriell In The News
Dr. David Pellman, chair of the CPMC research study's ICOB, publishes an influential scientific paper on genetic changes that occurs in cancer cells.
Coriell President and CEO Dr. Michael Christman was invited to lecture at the Festival of Genomics in Boston, a distinguished scientific conference.
A cell line from the NIGMS Repository at Coriell has yielded a DNA sample that can serve as an international research standard.
By cultivating and exploring participant data, the CPMC Research Study Team published a scientific paper in a top personalized medicine publication.
The Institute springs eternal in the latest edition of the Discover Coriell newsletter! We delve into the $14M biobanking award Coriell received from the National Institutes of Health, touch on an important development for our cutting-edge stem cell program, and thank our Coriell ambassadors.
South Jersey Biz magazine identifies Dr. Dorit Berlin, Coriell's Director of Biobanking, as one of the region's leading researchers.
New Jersey Senator Cory Booker (D) met with Coriell leadership and staff and learned about the cutting-edge science taking place at the Institute.
Business publication identifies Coriell Institute and its for-profit spinoff venture as crucial components for regional prosperity.
Already the world's leading source for human induced pluripotent stem cell lines, Coriell has reached a significant benchmark with its program.
Dr. Jeffrey Brenner, a MacArthur Fellow and prominent voice in the ongoing healthcare reform discussion, visited Coriell in January and shared his progressive vision with staff.
Meet our Team
Click here to meet our leadership and scientific staff.